Drug Product Composition data of Tox21_300575 on PharmaCompass.com

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0INTERMEDIATES

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

185 RELATED EXCIPIENT COMPANIES

310EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as:
Molecular Formula
C10H12N4O3
Molecular Weight
236.23  g/mol
InChI Key
BXZVVICBKDXVGW-NKWVEPMBSA-N

Didanosine
1 2D Structure

Didanosine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
2.1.2 InChI
InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1
2.1.3 InChI Key
BXZVVICBKDXVGW-NKWVEPMBSA-N
2.1.4 Canonical SMILES
C1CC(OC1CO)N2C=NC3=C2NC=NC3=O
2.1.5 Isomeric SMILES
C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O
2.2 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 236.23 g/mol
Molecular Formula C10H12N4O3
XLogP3-1.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass236.09094026 g/mol
Monoisotopic Mass236.09094026 g/mol
Topological Polar Surface Area88.7 A^2
Heavy Atom Count17
Formal Charge0
Complexity348
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 6  
Drug NameDidanosine
Drug LabelDidanosine delayed-release capsules are an enteric-coated formulation of didanosine, (ddl), a synthetic purine nucleoside analogue active against the Human Immunodeficiency Virus (HIV). Didanosine delayed-release capsules, containing enteric-coated p...
Active IngredientDidanosine
Dosage FormCapsule, delayed rel pellets; Tablet, for suspension; For solution
RouteOral
Strength200mg; 250mg; 100mg; 125mg; 150mg; 10mg/ml; 400mg
Market StatusPrescription
CompanyMylan Pharms; Aurobindo; Aurobindo Pharma; Barr

2 of 6  
Drug NameVidex
PubMed HealthDidanosine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelVIDEX is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX EC Delayed-Re...
Active IngredientDidanosine
Dosage FormFor solution
RouteOral
Strength10mg/ml
Market StatusPrescription
CompanyBristol Myers Squibb

3 of 6  
Drug NameVidex ec
PubMed HealthDidanosine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelVIDEX EC is the brand name for an enteric-coated formulation of didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. VIDEX EC Delayed-Release Capsules, containing enteric-coated beadlets, are available for oral administrati...
Active IngredientDidanosine
Dosage FormCapsule, delayed rel pellets
RouteOral
Strength200mg; 250mg; 125mg; 400mg
Market StatusPrescription
CompanyBristol Myers Squibb

4 of 6  
Drug NameDidanosine
Drug LabelDidanosine delayed-release capsules are an enteric-coated formulation of didanosine, (ddl), a synthetic purine nucleoside analogue active against the Human Immunodeficiency Virus (HIV). Didanosine delayed-release capsules, containing enteric-coated p...
Active IngredientDidanosine
Dosage FormCapsule, delayed rel pellets; Tablet, for suspension; For solution
RouteOral
Strength200mg; 250mg; 100mg; 125mg; 150mg; 10mg/ml; 400mg
Market StatusPrescription
CompanyMylan Pharms; Aurobindo; Aurobindo Pharma; Barr

5 of 6  
Drug NameVidex
PubMed HealthDidanosine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelVIDEX is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX EC Delayed-Re...
Active IngredientDidanosine
Dosage FormFor solution
RouteOral
Strength10mg/ml
Market StatusPrescription
CompanyBristol Myers Squibb

6 of 6  
Drug NameVidex ec
PubMed HealthDidanosine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelVIDEX EC is the brand name for an enteric-coated formulation of didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. VIDEX EC Delayed-Release Capsules, containing enteric-coated beadlets, are available for oral administrati...
Active IngredientDidanosine
Dosage FormCapsule, delayed rel pellets
RouteOral
Strength200mg; 250mg; 125mg; 400mg
Market StatusPrescription
CompanyBristol Myers Squibb

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - FOR SOLUTION;ORAL - 10MG/ML

USFDA APPLICATION NUMBER - 20156

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Topical

read-more
read-more

Empty Capsules

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Emulsifying Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty